Sign in

CIK 0001339970

  • Non-accelerated filer
  • Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203435077
Phone
+1 858-731-8389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Option exercise President and CEO acquired 10,375 shares (option exercise)
  4. 4 Open-market sale Chief Financial Officer sold 1,590 shares at $1.69 ($2,687)
  5. 4 Option exercise General Counsel acquired 2,688 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy President and CEO bought 15,000 shares at an average $1.18 ($17,646)
  10. 4 Open-market buy President and CEO bought 15,000 shares at an average $1.11 ($16,703)
  11. 4 Open-market buy President and CEO bought 15,000 shares at $2.01 ($30,224)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Gift Director gave 6,000 shares (gift)
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Director bought 200,000 shares at $2.25 ($450,000)
  19. 4 Option exercise Director acquired 6,000 shares (option exercise)
  20. 4 Option exercise Director acquired 6,000 shares (option exercise)

Page 3 of 17 · 329 filings